TAME study

Study / Research

Targeting Aging with Metformin, a proposed human clinical trial to investigate Metformin's longevity benefits in non-diabetic individuals, inspired by epidemiological data.

Mentioned in 3 videos

Videos Mentioning TAME study

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

#118 – Lloyd Klickstein, M.D., Ph.D.: Rapamycin, mTOR inhibition, and the biology of aging

Peter Attia MD

Targeting Aging with Metformin, a study led by Nir Barzilai to investigate if Metformin can prevent or delay age-related diseases in non-diabetic individuals.

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

Peter Attia MD

Targeting Aging with Metformin, a proposed human clinical trial to investigate Metformin's longevity benefits in non-diabetic individuals, inspired by epidemiological data.

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?

#66 – Vamsi Mootha, MD: Aging, T2D, cancer, dementia, Parkinson’s—do all roads lead to mitochondria?

Peter Attia MD

A study aiming to determine if Metformin can enhance longevity in non-diabetic, non-insulin resistant individuals.